GSK3B and Alzheimer disease: Tukey’s post hoc tests indicated that phosphorylation of GSK3β at Tyr216 was significantly up-regulated in the 3 × Tg-AD control group compared to that of the non-Tg control group (p < 0.001; Figure 2C).